CVRdatabase
Menu

Walmar Clinical ApS

Private limited companyCVR 43237381SnekkerstenActive

Walmar Clinical ApS is a private limited company, based in Snekkersten, active in research and experimental development on natural sciences and engineering, founded in 2022. Net profit fell 15% from 2024 to 2025, ending at DKK 528k. Equity grew to DKK 932k in 2025.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 1.8m−5.1% vs. 2024
Net profitDKK 528k−15.3% vs. 2024
EquityDKK 932k+39.9% vs. 2024
Employees2latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit fell 5% (2024 → 2025), to DKK 1.8m.
  • Net profit fell 15% (2024 → 2025), to DKK 528k.
  • Equity rose 40% (2024 → 2025), to DKK 932k.

Registrations, last 24 months

  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2022–2025 · amounts in DKK thousand

Equity and net profit

DKK 0DKK 200kDKK 400kDKK 600kDKK 800kDKK 1m2022202320242025
EquityNet profit
Financial figures for Walmar Clinical ApS
2022202320242025Change
Revenuenot statednot statednot statednot stated–
Gross profit1,1251,9101,9461,848−5.1%
Operating profit (EBIT)733775800679−15.1%
Profit before tax782931800679−15.1%
Net profit610725623528−15.3%
Total assets9692,1212,4192,684+11%
Equity650775666932+39.9%
Liabilities3191,3461,7531,752−0%
Cash and cash equivalents323281633859+35.8%
Average number of employees11110%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 200kDKK 400kDKK 600kDKK 800kDKK 1mDKK 1.2mDKK 1.4mDKK 1.6mDKK 1.8mDKK 2m2022202320242025
Gross profitMedian, the industry (431 companies)

Annual reports

4 financial years
Annual reports for Walmar Clinical ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202527/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202425/06/2025The companyPDFXBRL
202301/01/2023 – 31/12/202328/06/2024The companyPDFXBRL
202203/05/2022 – 31/12/202222/06/2023The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
0112208/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profitDKK 1.8mNo. 161 of 421
Better than 62% of the companies in the industry
EquityDKK 932kNo. 243 of 431
Better than 44% of the companies in the industry
Number of employees2No. 351 of 431
Better than 19% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bnHere
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 32,587of 69,742
Better than 53%
No. 34,594of 69,964
Better than 51%
Same industry and fewer than 20 employees329 companies in the comparison
No. 90of 323
Better than 72%
No. 155of 329
Better than 53%
Companies that are founded within the last five years16,662 companies in the comparison
No. 6,059of 16,614
Better than 64%
No. 4,087of 16,661
Better than 75%
All companies of type ApS66,508 companies in the comparison
No. 31,550of 66,379
Better than 52%
No. 30,446of 66,505
Better than 54%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Walmar Clinical ApSDKK 1.8m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Walmar Clinical ApSDKK 528k
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Walmar Clinical ApSDKK 932k
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Walmar Clinical ApS2
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • 26c Holding ApS100%
Walmar Clinical ApS

Management

1 active registrations

Executive management

Executive management at Walmar Clinical ApS
NameRoleAppointed
Mikkel WalmarDirector03/05/2022
Founders
Mikkel Walmar, Pernille Gry Hansen

Signing rule: Selskabet tegnes af en direktør.

Address and production units

1 active production units

Stolbjergvej 26C
3070 Snekkersten

Helsingør Municipality · Postcode 3070

Production units
Production unitAddressEmployeesP number
Walmar Clinical ApSStolbjergvej 26C, 3070 Snekkersten21028220843

Purpose

Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.

The purpose is quoted from the register in Danish.

Changes year by year

12 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
20252 changesaccounts 1 · industry 1
  • Annual report for 2024 published
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
20241 changeaccounts 1
  • Annual report for 2023 published
20234 changesaccounts 1 · ownership 3
  • Annual report for 2022 published
  • 26c Holding ApS registered as owner (100%)
  • Mikkel Walmar is no longer registered as owner
  • Pernille Gry Hansen is no longer registered as owner
20224 changesfounded 1 · management 1 · ownership 2
  • Registered as Walmar Clinical ApS
  • Mikkel Walmar appointed director
  • Mikkel Walmar registered as owner (50%)
  • Pernille Gry Hansen registered as owner (50%)

Related companies

Same industry in Helsingør

See all →

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction